Behandlung der akuten Kolitis beim Pferd^[*]

 

^* Modifizierter Nachdruck. Quelle: Compendium Equine, Continuing Education for Veterinarians 2009; 11/12: 416–424, Veterinary Learning Systems, Yardley, Pennsylvania, USA. In den Fußnoten finden sich Anmerkungen der Gutachter.

• Literatur

• 1 Mair TS, de Westerlaken LV, Cripps PJ. et al. Diarrhoea in adult horses: a survey of clinical cases and an assessment of some prognostic indices. Vet Rec 1990; 126: 479-481.
• 2 Seahorn JL, Seahorn TL. Fluid therapy in horses with gastrointestinal disease. Vet Clin North Am Equine Pract 2003; 19: 665-679.
• 3 McConnico R. Acute equine colitis. Compend Contin Educ Pract Vet 2003; 25: 625-631.
• 4 Schmall LM, Muir WW, Robertson JT. Haemodynamic effects of small volume hypertonic saline in experimentally induced haemorrhagic shock. Equine Vet J 1990; 22: 273-277.
• 5 Murray MJ. Therapeutic procedures for horses with colitis. Vet Med 1990: 510-518.
• 6 Dart AJ, Snyder JR, Spier SJ. et al. Ionized calcium concentration in horses with surgically managed gastrointestinal disease: 147 cases (1988–1990). JAVMA 1992; 201: 1244-1248.
• 7 Toribio RE, Kohn CW, Rourke KM. et al. Effects of hypercalcemia on serum concentrations of magnesium, potassium, and phosphate and urinary excretion of electrolytes in horses. Am J Vet Res 2007; 68: 543-554.
• 8 Krishnan RG, Coulthard MG. Minimising changes in plasma calcium and magnesium concentrations during plasmapheresis. Pediatr Nephrol 2007; 22: 1763-1766.
• 9 Borer KE, Corley KTT. Electrolyte disorders in horses with colic. Part 1: potassium and magnesium. Equine Vet Educ 2006; 18: 266-271.
• 10 O’Brien DP, Kroll RA, Johnson GC. et al. Myelinolysis after correction of hyponatremia in two dogs. J Vet Intern Med 1994; 8: 40-48.
• 11 Corley KTT, Marr CM. Pathophysiology, assessment and treatment of acidbase disturbances in the horse. Equine Vet Educ 1998; 10: 255-265.
• 12 Jones PA, Bain FT, Byars TD. et al. Effect of hydroxyethyl starch infusion on colloid oncotic pressure in hypoproteinemic horses. JAVMA 2001; 218: 1130-1135.
• 13 Dolente BA, Wilkins PA, Boston RC. Clinicopathological evidence of disseminated intravascular coagulation in horses with acute colitis. JAVMA 2002; 220: 1034-1038.
• 14 Jones PA, Tomasic M, Gentry PA. Oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies. Am J Vet Res 1997; 58: 541-548.
• 15 Blikslager AT, Roberts MC. Mechanisms of intestinal mucosal repair. JAVMA 1997; 211: 1437-1441.
• 16 Semrad SD, Hardee GE, Hardee MM. et al. Low dose flunixin meglumine: effects on eicosanoid production and clinical signs induced by experimental endotoxaemia in horses. Equine Vet J 1987; 19: 201-206.
• 17 Yamada T, Deitch E, Specian RD. et al. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 1993; 17: 641-662.
• 18 Leite AZ, Sipahi AM, Damião AO. et al. Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism. Gut 2001; 48: 163-167.
• 19 Semrad SD, Moore JN. Effects of multiple low doses of flunixin meglumine on repeated endotoxin challenge in the horse. Prostaglandins Leukot Med 1987; 27: 169-181.
• 20 Soriano-Brucher H, Avendano P, O’Ryan M. et al. Bismuth subsalicylate in the treatment of acute diarrhea in children: a clinical study. Pediatrics 1991; 87: 18-27.
• 21 Ericsson CD, Evans DG, DuPont HL. et al. Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae. J Infect Dis 1977; 136: 693-696.
• 22 Drew JE, Arthur JR, Farquharson AJ. et al. Salicylic acid modulates oxidative stress and glutathione peroxidase activity in the rat colon. Biochem Pharmacol 2005; 70: 888-893.
• 23 Bierer DW. Bismuth subsalicylate: history, chemistry, and safety. Rev Infect Dis 1990; 12 (Suppl. 01) S3-S8.
• 24 Rateau JG, Morgant G, Droy-Priot MT. et al. A histological, enzymatic and water-electrolyte study of the action of smectite, a mucoprotective clay, on experimental infectious diarrhoea in the rabbit. Curr Med Res Opin 1982; 8: 233-241.
• 25 Herthel D. Treatment of clostridial colitis with smectite. Proc 6th Annu Colic Res Symp 1998: 12.
• 26 Weese JS, Cote NM, deGannes RV. Evaluation of in vitro properties of di-trioctahedral smectite on clostridial toxins and growth. Equine Vet J 2003; 35: 638-641.
• 27 Rager KD, George LW, House JK. et al. Evaluation of rumen transfaunation after surgical correction of left-sided displacement of the abomasum in cows. JAVMA 2004; 225: 915-920.
• 28 Weese JS, Rousseau J. Evaluation of Lactobacillus pentosus WE7 for prevention of diarrhea in neonatal foals. JAVMA 2005; 226: 2031-2034.
• 29 Desrochers AM, Dolente BA, Roy MF. et al. Efficacy of Saccharomyces boulardii for treatment of horses with acute enterocolitis. JAVMA 2005; 227: 954-959.
• 30 Castagliuolo I, Riegler MF, Valenick L. et al. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun 1999; 67: 302-307.
• 31 Buts JP, Bernasconi P, Vaerman JP. et al. Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci 1990; 35: 251-256.
• 32 Papich MG. Antimicrobial therapy for gastrointestinal diseases. Vet Clin North Am Equine Pract 2003; 19: 645-663 vi.
• 33 Palmer JE, Benson CE, Whitlock RH. Effect of treatment with oxytetracycline during the acute stages of experimentally induced equine ehrlichial colitis in ponies. Am J Vet Res 1992; 53: 2300-2304.
• 34 Baverud V, Gustafsson A, Franklin A. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility. Equine Vet J 2003; 35: 465-471.
• 35 Baverud V, Gunnarsson A, Karlsson M. et al. Antimicrobial susceptibility of equine and environmental isolates of Clostridium difficile. Microb Drug Resist 2004; 10: 57-63.
• 36 Moore JN. Introduction to endotoxemia. Proc Annu Conv AAEP 1995; 41: 100-102.
• 37 Barton MH, Parviainen A, Norton N. Polymyxin B protects horses against induced endotoxaemia in vivo. Equine Vet J 2004; 36: 397-401.
• 38 MacKay RJ, Clark CK, Logdberg L. et al. Effect of a conjugate of polymyxin B-dextran 70 in horses with experimentally induced endotoxemia. Am J Vet Res 1999; 60: 68-75.
• 39 Morresey PR, Mackay RJ. Endotoxin-neutralizing activity of polymyxin B in blood after IV administration in horses. Am J Vet Res 2006; 67: 642-647.
• 40 Parviainen AK, Barton MH, Norton NN. Evaluation of polymyxin B in an ex vivo model of endotoxemia in horses. Am J Vet Res 2001; 62: 72-76.
• 41 Gaffin SL, Wells MT. A morphological study of the action of equine anti-lipopolysaccharide plasma on gram-negative bacteria. J Med Microbiol 1987; 24: 165-168.
• 42 Moore JN, Barton MH. Treatment of endotoxemia. Vet Clin North Am Equine Pract 2003; 19: 681-695.
• 43 Traub-Dargatz JL, Dargatz DA. A retrospective study of vein thrombosis in horses treated with intravenous fluids in a veterinary teaching hospital. J Vet Intern Med 1994; 8: 264-266.
• 44 Divers TJ. Prevention and treatment of thrombosis, phlebitis, and laminitis in horses with gastrointestinal diseases. Vet Clin North Am Equine Pract 2003; 19: 779-790.
• 45 Hinckley KA, Fearn S, Howard BR. et al. Glyceryl trinitrate enhances nitric oxide mediated perfusion within the equine hoof. J Endocrinol 1996; 151: R1-8.
• 46 van Eps AW, Pollitt CC. Equine laminitis: cryotherapy reduces the severity of the acute lesion. Equine Vet J 2004; 36: 255-260.
• 47 Weiss DJ, Evanson OA, McClenahan D. et al. Effect of a competitive inhibitor of platelet aggregation on experimentally induced laminitis in ponies. Am J Vet Res 1998; 59: 814-817.
• 48 Weiss DJ, Evanson OA. Evaluation of lipopolysaccharide-induced activation of equine neutrophils. Am J Vet Res 2002; 63: 811-815.
• 49 Divers TJ. COX inhibitors: making the best choice for the laminitic case. J Equine Vet Sci 2008; 28: 367-369.
• 50 Kim LM, Morley PS, Traub-Dargatz JL. et al. Factors associated with Salmonella shedding among equine colic patients at a veterinary teaching hospital. JAVMA 2001; 218: 740-748.
• 51 Cohen ND, Martin LJ, Simpson RB. et al. Comparison of polymerase chain reaction and microbiological culture for detection of salmonellae in equine feces and environmental samples. Am J Vet Res 1996; 57: 780-786.
• 52 Cohen ND, Woods AM. Characteristics and risk factors for failure of horses with acute diarrhea to survive: 122 cases (1990–1996). JAVMA 1999; 214: 382-390.
• 53 Robinson NE, Sprayberry K. eds. Current Therapy in Equine Medicine. 6th ed. Philadelphia: WB Saunders;; 2008
• 54 Sweeney RW, Soma LR, Woodward CB, Charlton CB. Pharmacokinetics of metronidazole given to horses by intravenous and oral routes. Am J Vet Res 1986; 47 (Suppl. 08) 1726-1729.